BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1339738)

  • 1. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of postoperative determination of CEA in carcinoma of the large intestine].
    Florianello F; Gorla C; Biraghi T; Caron R; Scortecci V
    Minerva Med; 1986 Apr; 77(18):739-41. PubMed ID: 3714087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of CEA in postoperative monitoring of colorectal cancers].
    Cossu F; Fodde M; Ledda P; Pisano G; Rombi GP; Scintu F; Tuveri A
    Minerva Med; 1984 Oct; 75(40):2373-80. PubMed ID: 6504398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
    Carpelan-Holmström MA; Haglund CH; Järvinen HJ; Roberts PJ
    Anticancer Res; 1996; 16(2):981-6. PubMed ID: 8687164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
    Terabe K; Ichihashi H; Kamei H; Kondo T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
    Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
    Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of CEA in colorectal carcinoma].
    Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
    Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical applications of the carcinoembryonic antigen (CEA) determination in colorectal cancer (observations of 119 cases)].
    Sivelli R; Farinon AM; Chiampo L
    Chir Ital; 1980 Oct; 32(5):946-63. PubMed ID: 6166402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of radioimmunological serum levels of carcinoembryonic antigen in the postoperative monitoring of rectocolonic cancer].
    Reginster JY; Desaive C; Collette J; Zangerle PF; Denis D; Franchimont P
    Ann Gastroenterol Hepatol (Paris); 1984; 20(4):203-6. PubMed ID: 6529177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
    Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
    Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
    Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
    Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEA radioimmunoassay. Clinical applications in colorectal cancer.
    Huyghe J
    Acta Chir Belg; 1983; 83(2):77-88. PubMed ID: 6858539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of carcinoembryonic and carbohydrate antigens in the diagnosis of recurrences and metastases of rectal cancer].
    Ozhiganov EL; Kuznetsova LF
    Med Radiol (Mosk); 1986 Aug; 31(8):40-4. PubMed ID: 3462448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer.
    Onetto M; Paganuzzi M; Secco GB; Fardelli R; Santi F; Rovida S; Ferrara GB
    Biomed Pharmacother; 1985; 39(7):392-5. PubMed ID: 3830268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.